|
TMEM41A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.4841999851356E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.838700E-03 |
| Stage1-vs-Stage3 |
9.726200E-02 |
| Stage1-vs-Stage4 |
4.264800E-03 |
| Stage2-vs-Stage3 |
1.802040E-04 |
| Stage2-vs-Stage4 |
2.23279999999049E-05 |
| Stage3-vs-Stage4 |
2.851400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.15339959805283E-10 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
2.065400E-01 |
| Caucasian-vs-Asian |
8.948600E-01 |
| AfricanAmerican-vs-Asian |
3.007000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.175800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.680300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.866800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.865990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.100400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.594200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.307600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.326600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.115700E-03 |
| Classical-VS-Follicular |
5.7065463465733E-14 |
| Classical-VS-Other |
3.838800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.4213963339671E-11 |
| Tall-VS-Other |
1.887810E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.372600E-01 |
| Follicular-VS-Normal |
2.63566946046012E-13 |
| Other-VS-Normal |
1.418780E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62458935193399E-12 |
| N0-vs-N1 |
5.678300E-02 |
|
|
